$BXMT
BLACKSTONE MORTGAGE TRUST, INC.

2022 Q1 Form 10-Q Financial Statement

#000106163022000026 Filed on April 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $234.4M $187.5M
YoY Change 25.01% -8.48%
Cost Of Revenue $124.2M $97.58M
YoY Change 27.28% -20.99%
Gross Profit $110.2M $89.95M
YoY Change 22.55% 10.5%
Gross Profit Margin 47.02% 47.96%
Selling, General & Admin $11.35M $9.904M
YoY Change 14.58% -3.84%
% of Gross Profit 10.29% 11.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.36M $10.60M
YoY Change 16.64% -10.19%
Operating Profit $97.87M $79.35M
YoY Change 23.35% 14.01%
Interest Expense $100.7M $78.40M
YoY Change 28.44%
% of Operating Profit 102.89% 98.81%
Other Income/Expense, Net
YoY Change
Pretax Income $100.4M $80.64M
YoY Change 24.51% -251.87%
Income Tax $146.0K $101.0K
% Of Pretax Income 0.15% 0.13%
Net Earnings $99.69M $79.90M
YoY Change 24.76% -249.63%
Net Earnings / Revenue 42.52% 42.61%
Basic Earnings Per Share $0.59 $0.54
Diluted Earnings Per Share $0.58 $0.54
COMMON SHARES
Basic Shares Outstanding 169.3M shares 147.3M shares
Diluted Shares Outstanding 175.6M shares 147.3M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $309.4M $280.1M
YoY Change 10.46% -21.09%
Cash & Equivalents $309.4M $280.1M
Short-Term Investments
Other Short-Term Assets $23.67M $9.694M
YoY Change 144.18% 384.7%
Inventory
Prepaid Expenses
Receivables $94.94M $67.47M
Other Receivables $0.00 $0.00
Total Short-Term Assets $428.0M $357.3M
YoY Change 19.8% -16.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $77.60M
YoY Change -100.0% 0.78%
Other Assets
YoY Change
Total Long-Term Assets $23.64B $17.00B
YoY Change 39.08% 4.1%
TOTAL ASSETS
Total Short-Term Assets $428.0M $357.3M
Total Long-Term Assets $23.64B $17.00B
Total Assets $24.07B $17.35B
YoY Change 38.69% 3.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.01M $3.784M
YoY Change 190.83% -36.93%
Accrued Expenses $60.97M $41.32M
YoY Change 47.53% -12.08%
Deferred Revenue
YoY Change
Short-Term Debt $6.254M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $183.8M $136.3M
YoY Change 34.88% -0.54%
LONG-TERM LIABILITIES
Long-Term Debt $19.21B $13.28B
YoY Change 44.61% 2.78%
Other Long-Term Liabilities $6.512M $30.83M
YoY Change -78.87% 34.02%
Total Long-Term Liabilities $19.22B $13.31B
YoY Change 44.32% 2.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.8M $136.3M
Total Long-Term Liabilities $19.22B $13.31B
Total Liabilities $19.40B $13.47B
YoY Change 44.0% 2.78%
SHAREHOLDERS EQUITY
Retained Earnings -$799.0M
YoY Change
Common Stock $5.433B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.643B $3.883B
YoY Change
Total Liabilities & Shareholders Equity $24.07B $17.35B
YoY Change 38.69% 3.56%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $99.69M $79.90M
YoY Change 24.76% -249.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $90.10M $83.05M
YoY Change 8.49% 21.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.689B -$523.6M
YoY Change 222.53% 110.02%
Cash From Investing Activities -$1.689B -$523.6M
YoY Change 222.53% 110.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $52.16M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.360B $431.7M
YoY Change 215.06% 10.95%
NET CHANGE
Cash From Operating Activities $90.10M $83.05M
Cash From Investing Activities -$1.689B -$523.6M
Cash From Financing Activities $1.360B $431.7M
Net Change In Cash -$238.6M -$8.850M
YoY Change 2595.58% -104.25%
FREE CASH FLOW
Cash From Operating Activities $90.10M $83.05M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-14788
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Blackstone Mortgage Trust, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
172647000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
273797000 USD
CY2022Q1 us-gaap Assets
Assets
24068841000 USD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-6181186
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
345 Park Avenue
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10154
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
655-0220
CY2022Q1 dei Security12b Title
Security12bTitle
Class A common stock,
CY2022Q1 dei Trading Symbol
TradingSymbol
BXMT
CY2021Q4 us-gaap Assets
Assets
22703289000 USD
CY2022Q1 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
243760000 USD
CY2021Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
0 USD
CY2022Q1 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
13092408000 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
170285852 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309425000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
551154000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23708990000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 USD
CY2021Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
12280042000 USD
CY2022Q1 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2839818000 USD
CY2021Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2838062000 USD
CY2022Q1 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
463097000 USD
CY2021Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
393824000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001061630
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1682000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5431627000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5373029000 USD
CY2022Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
1325222000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4642938000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8600000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8308000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-798992000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4588187000 USD
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
1327406000 USD
CY2022Q1 us-gaap Senior Notes
SeniorNotes
394303000 USD
CY2021Q4 us-gaap Senior Notes
SeniorNotes
394010000 USD
CY2022Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
850084000 USD
CY2021Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
619876000 USD
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
190312000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
231358000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
19399004000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
18084578000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
26899000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
30524000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24068841000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4669837000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4618711000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
170283071 shares
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-794832000 USD
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
170283071 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168179798 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168179798 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1703000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22703289000 USD
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
234432000 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
187524000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
100714000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
78372000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
133718000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
109152000 USD
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
23486000 USD
CY2021Q1 us-gaap Management Fee Expense
ManagementFeeExpense
19207000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12360000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10597000 USD
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
35846000 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
29804000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147336936 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175602905 shares
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-2537000 USD
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1293000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100409000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
80641000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
146000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
101000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
80540000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
576000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
638000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
79902000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2021Q1 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-9325000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147336936 shares
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
80540000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-45222000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-34957000 USD
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-684000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
576000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
638000 USD
CY2022Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
45514000 USD
CY2021Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
35071000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
114000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
100555000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
80654000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
99979000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
80016000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3904231000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7958000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-3755000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
204000 USD
CY2021Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
125000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
80540000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
114000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q1 us-gaap Dividends
Dividends
91349000 USD
CY2021Q1 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
13448000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11180000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9162000 USD
CY2022Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
-2537000 USD
CY2021Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
-1293000 USD
CY2022Q1 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-21000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
52159000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3904093000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4618711000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
8472000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
246000 USD
CY2022Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
173000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 USD
CY2022Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
2437000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q1 us-gaap Dividends
Dividends
105801000 USD
CY2022Q1 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
5040000 USD
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9241000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4669837000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
80540000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8650000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8085000 USD
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
18573000 USD
CY2021Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
14212000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10530000 USD
CY2021Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
-3799000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10319000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
359000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3858000 USD
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
1179632000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2896000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90098000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83048000 USD
CY2022Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
2924418000 USD
CY2021Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1405119000 USD
CY2021Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
862204000 USD
CY2022Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
29775000 USD
CY2021Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
17475000 USD
CY2022Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
28981000 USD
CY2021Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
7287000 USD
CY2022Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
2720000 USD
CY2021Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
56488000 USD
CY2022Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
0 USD
CY2021Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
48853000 USD
CY2022Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
147726000 USD
CY2021Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
38734000 USD
CY2022Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
78659000 USD
CY2021Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
0 USD
CY2022Q1 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
245278000 USD
CY2021Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
35860000 USD
CY2022Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
0 USD
CY2021Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
86910000 USD
CY2021Q1 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
0 USD
CY2022Q1 bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
0 USD
CY2021Q1 bxmt Proceeds From Issuance Of Secured Term Loan
ProceedsFromIssuanceOfSecuredTermLoan
198500000 USD
CY2022Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
3435000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1688750000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-523591000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2093695000 USD
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5040000 USD
CY2021Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
3191000 USD
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11616000 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
9279000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1222548000 USD
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1205929000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
878030000 USD
CY2022Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
0 USD
CY2021Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
13448000 USD
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
9241000 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
11180000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52155000 USD
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
294000000 USD
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
64650000 USD
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2022Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
2924418000 USD
CY2022Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
2924418000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
104271000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
91004000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1360093000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
431693000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-238559000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8850000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551154000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
289970000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
280126000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
81984000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
67410000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3170000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-994000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309425000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
161000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-264000 USD
CY2022Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
105576000 USD
CY2021Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
91159000 USD
CY2022Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
4635000 USD
CY2021Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
2578000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">References herein to “Blackstone Mortgage Trust,” “Company,” “we,” “us” or “our” refer to Blackstone Mortgage Trust, Inc. and its subsidiaries unless the context specifically requires otherwise. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blackstone Mortgage Trust is a real estate finance company that originates senior loans collateralized by commercial real estate in North America, Europe, and Australia. Our portfolio is composed primarily of loans secured by high-quality, institutional assets in major markets, sponsored by experienced, well-capitalized real estate investment owners and operators. These senior loans are capitalized by accessing a variety of financing options, including borrowing under our credit facilities, issuing CLOs or single-asset securitizations, and syndicating senior loan participations, depending on our view of the most prudent financing option available for each of our investments. We are not in the business of buying or trading securities, and the only securities we own are the retained interests from our securitization financing transactions, which we have not financed. We are externally managed by BXMT Advisors L.L.C., or our Manager, a subsidiary of Blackstone Inc., or Blackstone, and are a real estate investment trust, or REIT, traded on the New York Stock Exchange, or NYSE, under the symbol “BXMT.” Our principal executive offices are located at 345 Park Avenue, 24th Floor, New York, New York 10154. We were incorporated in Maryland in 1998, when we reorganized from a California common law business trust into a Maryland corporation. </span></div>We conduct our operations as a REIT for U.S. federal income tax purposes. We generally will not be subject to U.S. federal income taxes on our taxable income to the extent that we annually distribute all of our net taxable income to stockholders and maintain our qualification as a REIT. We also operate our business in a manner that permits us to maintain an exclusion from registration under the Investment Company Act of 1940, as amended. We are organized as a holding company and conduct our business primarily through our various subsidiaries.
CY2017Q2 bxmt Joint Venture Capital Contribution Percentage
JointVentureCapitalContributionPercentage
0.85
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. As the novel coronavirus, or COVID-19, pandemic has evolved from its emergence in early 2020, so has its global impact. During the course of the pandemic, many countries have re-instituted, or strongly encouraged, varying levels of quarantines and restrictions on travel and in some cases have at times limited operations of certain businesses and taken other restrictive measures designed to help slow the spread of COVID-19 and its variants. Governments and businesses have also instituted vaccine mandates and testing requirements for employees. While vaccine availability and uptake has increased, the longer-term macro-economic effects on global supply chains, inflation, labor shortages and wage increases continue to impact many industries, including the collateral underlying certain of our loans. Moreover, with the potential for new strains of COVID-19 to emerge, governments and businesses may re-impose aggressive measures to help slow its spread in the future. For this reason, among others, as the COVID-19 pandemic continues, the potential global impacts are uncertain and difficult to assess. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2022, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions as of March 31, 2022 inherently less certain than they would be absent the current and potential impacts of COVID-19 and geopolitical events. Actual results may ultimately differ materially from those estimates.</span></div>
CY2022Q1 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
Revenue Recognition Interest income from our loans receivable portfolio and debt securities is recognized over the life of each investment using the effective interest method and is recorded on the accrual basis. Recognition of fees, premiums, and discounts associated with these investments is deferred and recorded over the term of the loan or debt security as an adjustment to yield. Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of our Manager, recovery of income and principal becomes doubtful. Interest received is then recorded as a reduction in the outstanding principal balance until accrual is resumed when the loan becomes contractually current and performance is demonstrated to be resumed. In addition, for loans we originate, the related origination expenses are deferred and recognized as a component of interest income, however expenses related to loans we acquire are included in general and administrative expenses as incurred.
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
421800000 USD
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
531200000 USD
CY2022Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
23873563000 USD
CY2022Q1 bxmt Mortgage Loans On Real Estate Accounted For Under Cost Recovery Method
MortgageLoansOnRealEstateAccountedForUnderCostRecoveryMethod
286300000 USD
CY2022Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 SecurityLoan
CY2022Q1 bxmt Financing Receivable Number Of Loans Accounted For Under Cost Recovery Method
FinancingReceivableNumberOfLoansAccountedForUnderCostRecoveryMethod
1 loan
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 SecurityLoan
CY2022Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
23873563000 USD
CY2021Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
22156437000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2022Q1 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y6M
CY2021 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y4M24D
CY2021Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
22156437000 USD
CY2021Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-153420000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 USD
CY2021Q4 bxmt Financing Receivable Number Of Loans Accounted For Under Cost Recovery Method
FinancingReceivableNumberOfLoansAccountedForUnderCostRecoveryMethod
1 loan
CY2022Q1 bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
1047736000 USD
CY2022Q1 bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
-159556000 USD
CY2022Q1 bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
1047736000 USD
CY2022Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
1165000 USD
CY2022Q1 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
-158391000 USD
CY2022Q1 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
2153000 USD
CY2021Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
572000 USD
CY2022Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
29775000 USD
CY2022Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
29775000 USD
CY2022Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
17457000 USD
CY2022Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
17457000 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
78000000.0 USD
CY2022Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
637000 USD
CY2022Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
23873563000 USD
CY2022Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-164573000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23708990000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2022Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 SecurityLoan
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23708990000 USD
CY2022Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
25627588000 USD
CY2022Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2022Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 SecurityLoan
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23708990000 USD
CY2022Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
25627588000 USD
CY2022Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2022Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1800000000 USD
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 SecurityLoan
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 USD
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 USD
CY2021Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
94939000 USD
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 SecurityLoan
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 USD
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 USD
CY2021Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
956000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
0 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2021Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2022Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 SecurityLoan
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
23708990000 USD
CY2022Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
25627588000 USD
CY2021Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
188 SecurityLoan
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
86101000 USD
CY2022Q1 us-gaap Derivative Assets
DerivativeAssets
51884000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
22003017000 USD
CY2021Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
23669111000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
23586769000 USD
CY2021Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
21878338000 USD
CY2022Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1800000000 USD
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
30531000 USD
CY2022Q1 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
23034000 USD
CY2021Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
77624000 USD
CY2021Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1500000000 USD
CY2021Q4 bxmt Weighted Average Risk Rating On Loan Exposure
WeightedAverageRiskRatingOnLoanExposure
2.8
CY2022Q1 bxmt Weighted Average Risk Rating On Loan Exposure
WeightedAverageRiskRatingOnLoanExposure
2.8
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
173549000 USD
CY2021Q1 bxmt Financing Receivable Credit Loss Period Increase Increase Decrease Excluding Writeoff
FinancingReceivableCreditLossPeriodIncreaseIncreaseDecreaseExcludingWriteoff
-1449000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
172100000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 USD
CY2022Q1 bxmt Financing Receivable Credit Loss Period Increase Increase Decrease Excluding Writeoff
FinancingReceivableCreditLossPeriodIncreaseIncreaseDecreaseExcludingWriteoff
-2458000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-2500000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122200000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-1400000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
172100000 USD
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6241000 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5890000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
4000 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
78083000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
70000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
0 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
78013000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
172647000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
273797000 USD
CY2020Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
1723000 USD
CY2021Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityAllowanceForCreditLossPeriodIncreaseDecrease
-834000 USD
CY2021Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
889000 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
70000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityAllowanceForCreditLossPeriodIncreaseDecrease
-70000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityAllowanceForCreditLossPeriodIncreaseDecrease
-70000 USD
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0 USD
CY2021Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesHeldToMaturityAllowanceForCreditLossPeriodIncreaseDecrease
-834000 USD
CY2021Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
889000 USD
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
105576000 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
104271000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
37479000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
29851000 USD
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
23486000 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
28373000 USD
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
11005000 USD
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
9046000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
6254000 USD
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
6263000 USD
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6241000 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5890000 USD
CY2022Q1 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
271000 USD
CY2021Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
47664000 USD
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
190312000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
231358000 USD
CY2022Q1 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
3500000000 USD
CY2022Q1 bxmt Debt Instrument Covenant Maximum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMaximumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05
CY2022Q1 bxmt Credit Spread Adjustment
CreditSpreadAdjustment
0.0011
CY2022Q1 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
11000000 USD
CY2021Q4 bxmt Credit Spread Adjustment
CreditSpreadAdjustment
0.0011
CY2021Q1 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
12100000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6300000 USD
CY2022Q1 us-gaap Share Price
SharePrice
31.79
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
45510000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
35070000 USD
CY2022Q1 us-gaap Derivative Assets
DerivativeAssets
51884000 USD
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
30531000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
1000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
100700000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
78400000 USD
CY2022Q1 bxmt Stock Shares Authorized
StockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
225000 USD
CY2021Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
190000 USD
CY2022Q1 us-gaap Dividends
Dividends
105801000 USD
CY2021Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
168543370 shares
CY2020Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
147086722 shares
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1675639 shares
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
515 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
427634 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
250536 shares
CY2022Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
7063 shares
CY2021Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
11437 shares
CY2022Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
170653706 shares
CY2021Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
147349210 shares
CY2022Q1 bxmt Deferred Stock Units
DeferredStockUnits
370635 shares
CY2021Q1 bxmt Deferred Stock Units
DeferredStockUnits
318128 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
639 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
515 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
639 shares
CY2021Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
515 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2021Q1 us-gaap Dividends
Dividends
91349000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
79902000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147336936 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
79902000 USD
CY2022Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2400000 USD
CY2021Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
102087000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
79902000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147336936 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6348846 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175602905 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147336936 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8600000 USD
CY2022Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
131900000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-123300000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8300000 USD
CY2021Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
86400000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-78100000 USD
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125000 USD
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
2698000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
1819000 USD
CY2022Q1 bxmt Operating Loss Carryforwards Limitations On Use Annual Limitation
OperatingLossCarryforwardsLimitationsOnUseAnnualLimitation
2000000.0 USD
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000.0 USD
CY2022Q1 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
9 plan
CY2022Q1 bxmt Number Of Expired Benefit Plans
NumberOfExpiredBenefitPlans
7 plan
CY2022Q1 bxmt Number Of Current Benefit Plans
NumberOfCurrentBenefitPlans
2 plan
CY2022Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1012000 USD
CY2022Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8650000 USD
CY2021Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8085000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12360000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10597000 USD
CY2021Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
693000 USD
CY2022Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
3710000 USD
CY2021Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
2512000 USD
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
8477000 USD
CY2021Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
7960000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
173000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
146000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
101000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
79200000 USD
CY2021Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
400699000 USD
CY2022Q1 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2855625000 USD
CY2021Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2855625000 USD
CY2022Q1 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
469766000 USD
CY2022Q1 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
244367000 USD
CY2021Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
22156437000 USD
CY2022Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
309425000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
551154000 USD
CY2022Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
23873563000 USD
CY2022Q1 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
244400000 USD
CY2021Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
0 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
394804000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
16190702000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1004718000 USD
CY2022Q1 bxmt Nonconsolidated Securitized Debt Excluded From Contractual Obligations
NonconsolidatedSecuritizedDebtExcludedFromContractualObligations
1800000000 USD
CY2022Q1 bxmt Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.010
CY2022Q1 bxmt Securitized Debt Obligations Excluded From Contractual Obligations
SecuritizedDebtObligationsExcludedFromContractualObligations
2900000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3941558000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1828956000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6129112000 USD
CY2022Q1 bxmt Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
2891554000 USD
CY2022Q1 bxmt Board Of Directors Number Of Members
BoardOfDirectorsNumberOfMembers
9 director
CY2022Q1 bxmt Number Of Directors Eligible For Annual Compensation
NumberOfDirectorsEligibleForAnnualCompensation
6 director

Files In Submission

Name View Source Status
0001061630-22-000026-index-headers.html Edgar Link pending
0001061630-22-000026-index.html Edgar Link pending
0001061630-22-000026.txt Edgar Link pending
0001061630-22-000026-xbrl.zip Edgar Link pending
bxmt-20220331.htm Edgar Link pending
bxmt-20220331.xsd Edgar Link pending
bxmt-20220331_cal.xml Edgar Link unprocessable
bxmt-20220331_def.xml Edgar Link unprocessable
bxmt-20220331_g1.gif Edgar Link pending
bxmt-20220331_g2.jpg Edgar Link pending
bxmt-20220331_htm.xml Edgar Link completed
bxmt-20220331_lab.xml Edgar Link unprocessable
bxmt-20220331_pre.xml Edgar Link unprocessable
exhibit101.htm Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_01.jpg Edgar Link pending
image_1.jpg Edgar Link pending
image_11.jpg Edgar Link pending
image_21.jpg Edgar Link pending
image_2a.jpg Edgar Link pending
image_31.jpg Edgar Link pending
image_41.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending